IM Cannabis (IMCC) Change in Acquisitions & Divestments (2021)
IM Cannabis' (IMCC) quarterly Change in Acquisitions & Divestments came in at $239587.5 in Q4 2021, up 103.97% quarter-over-quarter from -$6.0 million in Q3 2021.
IM Cannabis (IMCC) Change in Acquisitions & Divestments (2021) Analysis & Trends
IM Cannabis' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at $239587.5 for Q4 2021.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $239587.5 in Q4 2021; TTM through Dec 2021 was $398372.2, a N/A change from a year earlier, with the FY2021 full-year figure at $254547.8, changed N/A from the prior year.
- Change in Acquisitions & Divestments rose to $239587.5 in Q4 2021 per IMCC's latest filing, from -$6.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $6.2 million in Q2 2021 and bottomed at -$6.0 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 239,587.50 |
| Dec 31, 2021 | 239,587.50 |
| Sep 30, 2021 | -6.04 Mn |
| Sep 30, 2021 | -6.04 Mn |
| Jun 30, 2021 | 6.19 Mn |
| Jun 30, 2021 | 6.19 Mn |
| Mar 31, 2021 | 13,431.69 |
| Mar 31, 2021 | 13,431.69 |